Department of Human Pathology and Oncology, Section of Advanced Surgical Oncology, University of Siena, Siena, Italy.
Ann Surg Oncol. 2011 Aug;18(8):2265-72. doi: 10.1245/s10434-010-1541-y. Epub 2011 Jan 26.
The purpose of this study is to analyze the diagnostic accuracy of MSCT in the identification of para-aortic lymph node metastases from gastric cancer.
A total of 92 consecutive patients with primary gastric cancer were prospectively submitted to preoperative MSCT staging according to a standard protocol in the period 2003-2010. All diagnostic procedures were performed by dedicated radiologists who were unaware of the final pathological nodal status. Subsequently all patients underwent potentially curative (R0) resection with extended lymphadenectomy plus para-aortic nodal dissection. Lymph node mapping in different stations and retrieval of single lymph nodes were performed by the surgeon on the fresh specimen and then submitted for pathological examination. Clinical, radiological, and pathological data were prospectively stored on database.
A median number of 47 (range: 18-114) total lymph nodes and 7 (range: 3-29) para-aortic lymph nodes were removed. In 13 of 92 included patients (14%), histological examination demonstrated para-aortic nodal metastases; MSCT was correctly positive in 11 of these cases (sensitivity: 85%). In 79 patients para-aortic nodes were not involved, and MSCT resulted correctly negative in 75 of these patients (specificity: 95%). Positive (PPV) and negative (NPV) predictive values were 73 and 97%, with a global accuracy of 93%.
MSCT performed according to a standard protocol by dedicated radiologists demonstrated high accuracy in preoperative identification of para-aortic nodal metastases from gastric cancer. These results may be useful in planning surgical approach or during clinical staging before neoadjuvant chemotherapy.
本研究旨在分析 MSCT 对胃癌腹膜后淋巴结转移的诊断准确性。
2003 年至 2010 年期间,前瞻性地对 92 例原发性胃癌患者进行术前 MSCT 分期,按标准方案进行。所有诊断程序均由专门的放射科医生进行,他们不知道最终的病理淋巴结状态。随后,所有患者均接受了潜在治愈性(R0)切除和扩大淋巴结清扫术加腹膜后淋巴结清扫术。外科医生在新鲜标本上对不同部位的淋巴结进行定位和单个淋巴结的采集,并进行病理检查。临床、放射学和病理学数据均前瞻性地存储在数据库中。
共切除了 47 个(范围:18-114 个)总淋巴结和 7 个(范围:3-29 个)腹膜后淋巴结。在 92 例患者中有 13 例(14%)病理检查发现腹膜后淋巴结转移;MSCT 在这 11 例中正确显示阳性(敏感性:85%)。在 79 例患者中,腹膜后淋巴结未受累,MSCT 在这 75 例中正确显示阴性(特异性:95%)。阳性(PPV)和阴性(NPV)预测值分别为 73%和 97%,总体准确性为 93%。
由专门的放射科医生按标准方案进行的 MSCT 术前对胃癌腹膜后淋巴结转移的诊断具有很高的准确性。这些结果可能有助于规划手术方法或在新辅助化疗前进行临床分期。